# UNRAVELLING THE MECHANISMS OF EPILEPSY-DEPRESSION COMORBIDITY IN A GENETIC MOUSE MODEL OF TEMPORAL LOBE EPILEPSY

> **NIH NIH K08** · BAYLOR COLLEGE OF MEDICINE · 2021 · $185,486

## Abstract

PROJECT SUMMARY/ABSTRACT
Symptoms of major depression and anxiety are a critical contributor to the overall disability in patients with
epilepsy and are associated with significantly lower rates of seizure freedom. Since depression in epilepsy can
arise either before or after the onset of seizures, many have proposed the presence of shared etiological
disease mechanisms that simultaneously elevate seizure risk and result in mood impairments with anhedonia.
The neuroanatomical and molecular mediators of this comorbidity are poorly understood. Developing specific
treatment strategies to ameliorate these disease mechanisms may coordinately address “ictal” (seizure-
related) and “interictal” (in between seizures) disability in a variety of epilepsy syndromes. This proposal
tackles this issue in the context of temporal lobe epilepsy, the most common form of epilepsy in adults, using a
combination of genetic mouse models, molecular tools and long-term home cage monitoring. The central
hypothesis of this proposal is that hyperactivity within neurons of the ventral CA1 region of the hippocampus
coordinately elevate seizure risk and produce depression-related symptoms. In Aim 1, the candidate will
employ a targeted chemogenetic approach in mice to examine how hyperactivity within these neurons may
impact depression-related behavior and seizure threshold. In Aim 2, using wireless electroencephalography,
the candidate will examine how selectively inhibiting these neurons might improve seizure burden and interictal
depression-like symptoms in a genetically valid mouse model of temporal lobe epilepsy and comorbid
depression. To quantify the pervasive psychomotor alterations and neurovegetative derangements associated
with depression-like syndromes, measurements of mouse behavior will be conducted within instrumented
home cage chambers designed to capture unbiased prolonged measurements (>23h) of multiple behavioral
variables while minimizing human contact. The candidate is an epileptologist with prior training in mouse
models of depression, anxiety and autism spectrum disorders. This proposal will be mentored Dr. Jeffrey
Noebels, an internationally renowned physician-scientist with expertise in the neuroqenetics of epilepsy who
has a strong track record of independent NIH funding and K mentorship. All experiments will be conducted
within the facilities of the Baylor College of Medicine, a highly ranked health sciences university with an
established reputation in the field of biomedical research. The candidate’s professional development and
training plan builds towards a career as a physician-scientist in the field of epilepsy psychiatric comorbidities,
and specifically incorporates gap-based training in wireless electroencephalography and various advanced
statistical techniques. Dr. Dennis Cox, Professor of Statistics at Rice University, will serve as a statistical
consultant. The completion of these aims will shed new light into the (i) function of specific ...

## Key facts

- **NIH application ID:** 10109160
- **Project number:** 5K08NS110924-03
- **Recipient organization:** BAYLOR COLLEGE OF MEDICINE
- **Principal Investigator:** Vaishnav Krishnan
- **Activity code:** K08 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $185,486
- **Award type:** 5
- **Project period:** 2019-03-15 → 2024-02-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10109160

## Citation

> US National Institutes of Health, RePORTER application 10109160, UNRAVELLING THE MECHANISMS OF EPILEPSY-DEPRESSION COMORBIDITY IN A GENETIC MOUSE MODEL OF TEMPORAL LOBE EPILEPSY (5K08NS110924-03). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10109160. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
